We are live on ! Find out more
GS

GTS Securities Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.76%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+21.76%
3 Year Est. Return
+68.93%
5 Year Est. Return
10 Year Est. Return
AUM
$46B
AUM Growth
-$945M
Cap. Flow
-$2.64B
Cap. Flow %
-5.74%
Top 10 Hldgs %
38.54%
Holding
4,570
New
696
Increased
1,653
Reduced
1,646
Closed
543

Sector Composition

Rank Sector Weight
1 Technology 2.2%
2 Consumer Discretionary 1.38%
3 Communication Services 0.71%
4 Healthcare 0.57%
5 Financials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGL icon
4051
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.05B
-7,599
Closed -$215K
ANSS
4052
CALL
DELISTED
Ansys
ANSS
-800
Closed -$257K
ANVS icon
4053
CALL
Annovis Bio
ANVS
$79.6M
-11,300
Closed -$65.1K
ANVS icon
4054
PUT
Annovis Bio
ANVS
$79.6M
-40,200
Closed -$232K
AOSL icon
4055
Alpha and Omega Semiconductor
AOSL
$1.01B
-17,195
Closed -$643K
AOS icon
4056
CALL
A.O. Smith
AOS
$8.61B
-20,300
Closed -$1.66M
ARB icon
4057
AltShares Merger Arbitrage ETF
ARB
$102M
-18,831
Closed -$507K
ARCC icon
4058
CALL
Ares Capital
ARCC
$14.1B
-16,300
Closed -$340K
ARCC icon
4059
Ares Capital
ARCC
$14.1B
-9,816
Closed -$204K
ARQQ icon
4060
CALL
Arqit Quantum
ARQQ
$383M
-2,580
Closed -$22.1K
ASAN icon
4061
CALL
Asana
ASAN
$2.02B
-44,300
Closed -$620K
ASO icon
4062
Academy Sports + Outdoors
ASO
$3.02B
-6,621
Closed -$361K
AVDL
4063
DELISTED
Avadel Pharmaceuticals
AVDL
-53,315
Closed -$812K
JBIO
4064
Jade Biosciences
JBIO
$1.3B
-591
Closed -$34.3K
AWI icon
4065
CALL
Armstrong World Industries
AWI
$7.74B
-4,300
Closed -$487K
AZEK
4066
DELISTED
The AZEK Co
AZEK
-8,344
Closed -$358K
AZEK
4067
PUT
DELISTED
The AZEK Co
AZEK
-8,800
Closed -$371K
BANC icon
4068
CALL
Banc of California
BANC
$3.09B
-11,960
Closed -$153K
BARK icon
4069
CALL
BARK
BARK
$89.6M
-555
Closed -$20.1K
BARK icon
4070
BARK
BARK
$89.6M
-905
Closed -$32.7K
BBJP icon
4071
JPMorgan BetaBuilders Japan ETF
BBJP
$18.4B
-21,046
Closed -$1.19M
BBUS icon
4072
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.18B
-19,344
Closed -$1.9M
BCRX icon
4073
BioCryst Pharmaceuticals
BCRX
$2.29B
-71,682
Closed -$545K
BCRX icon
4074
PUT
BioCryst Pharmaceuticals
BCRX
$2.29B
-13,800
Closed -$85.3K
BFEB icon
4075
Innovator US Equity Buffer ETF February
BFEB
$258M
-10,489
Closed -$426K

Similar funds

GTS Securities's Q3 2024 Portfolio in Review

As of Q3 2024, GTS Securities held 4,570 positions worth $46B, down 2% from $46.9B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

GTS Securities withdrew a net $2.64B in Q3 2024, closing 543 positions and reducing 1,646 holdings. Its most notable exit was ProShares UltraPro Short QQQ, an estimated $33.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, down from 2.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, GTS Securities opened a new position in ProShares UltraPro QQQ worth $23.2M.

  • GTS Securities's largest Q3 2024 buy was ProShares UltraPro QQQ: 640,308 shares worth $23.2M.
  • GTS Securities added most to Microsoft in Q3 2024, an estimated $112M increase.
  • GTS Securities's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $141M.
  • GTS Securities fully exited ProShares UltraPro Short QQQ in Q3 2024, selling an estimated $33.4M.
  • GTS Securities's ten largest holdings make up 39% of its $46B portfolio in Q3 2024.
  • GTS Securities opened 696 new positions and closed 543 in Q3 2024.
  • GTS Securities's portfolio value fell 2% quarter-over-quarter to $46B.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.